arrow
Back
J

J. Randolph Hecht

university of california

28H-index
139Paper Count
5.9KCitation Count
Published Papers 19
Publication Date
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: an ARCAD database study
err2025-10-02
err0
errOAAI
errKazumasa Yamamoto; Hideaki Bando; Toshihiro Misumi; Tomomi Nishikawa; Masashi Wakabayashi; Kentaro Yamazaki; Yoshihiko Maehara; Eiji Oki; Leonard B Saltz; Jean-Yves Douillard; Cornelis JA Punt; Miriam Koopman; Eric Van Cutsem; Carsten Bokemeyer; Alan P Venook; Volker Heinemann; Chiara Cremolini; J. Randolph Hecht; Hans-Joachim Schmoll; Goro Nakayama; Heinz-Josef Lenz; Thierry Andre; Qian Shi; Aimery de Gramont; Kohei Shitara; Takayuki Yoshino
errShare
errSave
STELLAR-303: randomized phase III study of zanzalintinib plus atezolizumab in previously treated metastatic colorectal cancer
err2024-07-23
err2
PREAI
errSaeed, Anwaar; Tabernero, Josep; Parikh, Aparna; den Eynde, Marc Van; Karthaus, Meinolf; Gerlinger, Marco; Wang, Zhong; Wang, Guan; Smith, Robina; Hecht, J. Randolph
errShare
errSave
BOLD-100-001: A phase II study of BOLD-100 in combination with FOLFOX in advanced mCRC patients that have failed at least two prior lines of therapy
err2024-06-01
err0
PREAI
errO'Kane, G. M.; Spratlin, J.; Oh, D-Y.; Rha, S. Y.; McWhirter, E.; Elimova, E.; Kavan, P.; Choi, M. K.; Kim, D.; Goodwin, R. A.; Hecht, J. R.; Koo, D-H.; Halani, K.; McAllister, R.; Jones, M.; Snow, M. D.; Lemmerick, Y.; Spera, G.; Pankovich, J.
errShare
errSave
Chronologic improvement in survival of first-line oxaliplatin based chemotherapy plus targeted therapy for metastatic colorectal cancer (mCRC): Analysis of the ARCAD database
err2024-06-01
err0
PREAI
errTakeda, Y.; Yamazaki, K.; Saltz, L.; Douillard, J-Y.; Punt, C. J. A.; Van Cutsem, E.; Bokemeyer, C.; Venook, A.; Koopman, M.; Heinemann, V.; Cremolini, C.; Hecht, J. R.; Schmoll, H. J. E-V.; Nakayama, G.; Sugihara, K.; Oki, E.; Andre, T.; Shi, Q.; De Gramont, A.; Yoshino, T.
errShare
errSave
AFNT-211: A phase1 study of autologous CD4+and CD8+T cells engineered to express a high avidity HLA-A*11:01-restricted, KRAS G12V-specific, transgenic TCR; CD8α/β coreceptor; and a FAS41BB switch receptor in patients with advanced/metastatic solid tumors
err2024-04-05
err0
PREAI
errMitchell, Shaunica; Khan, Binaish; Payumo, Francis; Chiorean, E. Gabriela; Gahvari, Zhubin; Hecht, J. Randolph; Hurwitz, Michael; Leidner, Rom; Lenz, Heinz-Josef; Pelster, Meredith; Punekar, Salman; Schoenfeld, Adam; Zhao, Dan; Vallaster, Markus; Nagorsen, Dirk
errShare
errSave
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
err2024-03-27
err16
PREAI
errRappaport, Amy R.; Kyi, Chrisann; Lane, Monica; Hart, Meghan G.; Johnson, Melissa L.; Henick, Brian S.; Liao, Chih-Yi; Mahipal, Amit; Shergill, Ardaman; Spira, Alexander I.; Goldman, Jonathan W.; Scallan, Ciaran D.; Schenk, Desiree; Palmer, Christine D.; Davis, Matthew J.; Kounlavouth, Sonia; Kemp, Lindsey; Yang, Aaron; Li, Yaojun John; Likes, Molly; Shen, Annie; Boucher, Gregory R.; Egorova, Milana; Veres, Robert L.; Espinosa, J. Aaron; Jaroslavsky, Jason R.; Tardif, Lauren D. Kraemer; Acrebuche, Lindsey; Puccia, Christopher; Sousa, Leiliane; Zhou, Rita; Bae, Kyounghwa; Hecht, J. Randolph; Carbone, David P.; Johnson, Benny; Allen, Andrew; Ferguson, Andrew R.; Jooss, Karin
errShare
errSave
Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases
err2023-04-01
err12
errOAAI
errHecht, J. R.; Raman, S. S.; Chan, A.; Kalinsky, K.; Baurain, J. -F.; Jimenez, M. M.; Garcia, M. M.; Berger, M. D.; Lauer, U. M.; Khattak, A.; Carrato, A.; Zhang, Y.; Liu, K.; Cha, E.; Keegan, A.; Bhatta, S.; Strassburg, C. P.; Roohullah, A.
errShare
errSave
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis
err2021-06-30
err2
errOAAI
errYin, Jun; Dawood, Shaheenah; Cohen, Romain; Meyers, Jeff; Zalcberg, John; Yoshino, Takayuki; Seymour, Matthew; Maughan, Tim; Saltz, Leonard; Van Cutsem, Eric; Venook, Alan; Schmoll, Hans-Joachim; Goldberg, Richard; Hoff, Paulo; Hecht, J. Randolph; Hurwitz, Herbert; Punt, Cornelis; Diaz Rubio, Eduard; Koopman, Miriam; Cremolini, Chiara; Heinemann, Volker; Tournigard, Christophe; Bokemeyer, Carsten; Fuchs, Charles; Tebbutt, Niall; Souglakos, John; Doulliard, Jean-Yves; Kabbinavar, Fairooz; Chibaudel, Benoist; de Gramont, Aimery; Shi, Qian; Grothey, Axel; Adams, Richard
errShare
errSave
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC)
err2020-09-10
err11
errOAAI
errHecht, J. Randolph; Papadopoulos, Kyriakos P.; Falchook, Gerald S.; Patel, Manish R.; Infante, Jeffrey R.; Aljumaily, Raid; Wong, Deborah J.; Autio, Karen A.; Wainberg, Zev A.; Bauer, Todd M.; Javle, Milind; Pant, Shubham; Bendell, Johanna; Hung, Annie; Ratti, Navneet; VanVlasselaer, Peter; Verma, Rakesh; Leveque, Joseph; Rao, Sujata; Oft, Martin; Naing, Aung
errShare
errSave
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens
err2020-07-08
err23
errOAAI
errWainberg, Zev A.; Feeney, Kynan; Lee, Myung Ah; Munoz, Andres; Cubillo Gracian, Antonio; Lonardi, Sara; Ryoo, Baek-Yeol; Hung, Annie; Lin, Yong; Bendell, Johanna; Hecht, J. Randolph
errShare
errSave
Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented
err2017-05-04
err22
errOAAI
errCalais, Jeremie; Czernin, Johannes; Eiber, Matthias; Fendler, Wolfgang P.; Gartmann, Jeannine; Heaney, Anthony P.; Hendifar, Andrew E.; Pisegna, Joseph R.; Hecht, J. Randolph; Wolin, Edward M.; Slavik, Roger; Gupta, Pawan; Quon, Andrew; Schiepers, Christiaan; Allen-Auerbach, Martin S.; Herrmann, Ken
errShare
errSave
HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-O13/LOGiC Trial of Lapatinib
err2017-01-05
err39
errOAAI
errPress, Michael F.; Ellis, Catherine E.; Gagnon, Robert C.; Grob, Tobias J.; Buyse, Marc; Villalobos, Ivonne; Liang, Zhiyong; Wu, Shafei; Bang, Yung-Jue; Qin, Shu-Kui; Chung, Hyun Cheol; Xu, Jianming; Park, Joon Oh; Jeziorski, Krzysztof; Afenjar, Karen; Ma, Yanling; Estrada, Monica C.; Robinson, Douglas M.; Scherer, Stefan J.; Sauter, Guido; Hecht, J. Randolph; Slamon, Dennis J.
errShare
errSave
errShare
errSave
Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction
err2011-08-02
err68
errOAAI
errWainberg, Z. A.; Lin, L-S; DiCarlo, B.; Dao, K. M.; Patel, R.; Park, D. J.; Wang, H-J; Elashoff, R.; Ryba, N.; Hecht, J. R.
errShare
errSave
Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer
errCANCER
IF5.1
err2007-08-20
err183
errOAAI
errHecht, J. Randolph; Patnaik, Amita; Berlin, Jordan; Venook, Alan; Malik, Lmtiaz; Tchekmedyian, Simon; Navale, Lynn; Amado, Rafael G.; Meropol, Neal J.
errShare
errSave
Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer
err2007-03-01
err89
PREAI
errBerlin, Jordan; Posey, James; Tchekmedyian, Simon; Hu, Eddie; Chan, David; Malik, Imtiaz; Yang, Liqiang; Amado, Rafael G.; Hecht, J. Randolph
errShare
errSave
Long-Term Data for Endoscopic Ultrasound (EUS) and Percutanous (PTA) Guided Intratumoral TNFerade Gene Delivery Combined with Chemoradiation in the Treatment of Locally Advanced Pancreatic Cancer (LAPC)
err2006-04-01
err23
PREAI
errFarrell, James J.; Senzer, N.; Hecht, J. R.; Hanna, N.; Chung, T.; Nemunaitis, J.; Rosemurgy, A.; Javle, M.; Reid, T.; Posner, M.; Macko, J.; Chang, K.
errShare
errSave